TScan Therapeutics, Inc.
TScan Therapeutics, Inc. (TCRX) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 49 transactions totaling $27.9M, demonstrating a bullish sentiment with $25.8M in net insider flow. The most recent transaction on Jan 20, 2026 involved a transaction of 1,165,000 shares valued at $0.
TCRX Insider Activity Summary
Who Is Buying TCRX Stock?
No significant insider buying has been recorded for TCRX in the recent period.
Who Is Selling TCRX Stock?
No significant insider selling has been recorded for TCRX in the recent period.
Is TScan Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TCRX is bullish with an Insider Alignment Score of 96/100 and a net flow of $25.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TCRX Frequently Asked Questions
Understanding TCRX Insider Activity
Insider trading at TScan Therapeutics, Inc. (TCRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading TCRX stock, having executed 49 transactions in the past 90 days. The most active insider is L.p. 667, (Executive), who has made 10 transactions totaling $23.9M.
Related Tools
Track TScan Therapeutics, Inc. Insider Activity
Get notified when executives and directors at TCRX file new Form 4 transactions